This article documents and then examines the various benefits that, it is claimed, will flow from linking the Unique Identity number with the public distribution system and the National Rural Employment Guarantee Scheme. It filters the unfounded claims, which arise from a poor understanding of how the PDS and NREGS function, from the genuine ones. On the latter, there are several demanding conditions that need to be met in order...

India’s drug regulator has refused to disclose key information about a controversial government study that provided Indian girls a vaccine designed to protect them from cervical cancer, amplifying suspicions about the study’s objectives. The Drug Controller General of India (DCGI) has refused to release for public scrutiny the study’s protocols, which are expected to contain information about its purpose and methodology, a set of health activists said yesterday. The Union government had...

The budget session of the Parliament began with President Pratibha Patil’s address. All indications point to a normal functioning of this session, unlike the wasted winter session.  This is because the UPA 2 government has agreed to constitute a Joint Parliamentary Committee (JPC) to look into the 2G spectrum allocation scam. If the government were to have done this in the winter session itself, then precious time and resources would...

Said it failed to state ethical aspects involved in the study Proposal was based on the assumption that vaccine was safe and efficacious: PHFI Brinda demands compensation for all subjects victimised by vaccine programme The proposal for conducting the now controversial “Post-licensure observational study of Human Papilloma Virus (HPV) vaccination: Demonstration Project,” carried out by a non-governmental organisation PATH for two major pharmaceutical companies, had been turned down by the Public Health Foundation...

Rules out blanket ban on or approval of such studies ‘HPV vaccination should supplement cervical cancer screening programme' The three-member committee, set up to probe the alleged irregularities in conducting studies using human papillomavirus (HPV) vaccine by PATH in India, has identified several deficiencies in the planning and implementation of the project leading “to a crisis requiring suspension of the study,” but has fallen short of fixing responsibility on any individual or...